GRN

MetroHealth Joins Guardian Research Network to Expand Research, Patient Care Opportunities

Retrieved on: 
Tuesday, May 2, 2023

SPARTANBURG, S.C., May 2, 2023 /PRNewswire/ -- Guardian Research Network®  (GRN) announced today that The MetroHealth System, a multi-hospital safety-net health system serving more than 300,000 Ohio patients, has joined its nationwide healthcare research consortium. This partnership will augment MetroHealth's efforts to become the national leader in translational innovations and discoveries that can improve the health and wealth for all members of the community. Through this strategic collaboration, GRN will continue to leverage real world data (RWD) analytics to strengthen community health initiatives around the country.

Key Points: 
  • SPARTANBURG, S.C., May 2, 2023 /PRNewswire/ -- Guardian Research Network ® (GRN) announced today that The MetroHealth System , a multi-hospital safety-net health system serving more than 300,000 Ohio patients, has joined its nationwide healthcare research consortium.
  • This relationship will open doors to new research opportunities and contribute to the continued growth of MetroHealth's robust translational research programs.
  • Together, GRN and MetroHealth will use these new advances to empower more personalized and clinically impactful care for better outcomes.
  • "We're extremely excited about bringing MetroHealth into our network," said Shirley Trainor-Thomas, vice president, Partner Network of GRN.

GRN Holding Corporation Continues To Execute Business Plan With Acquisition Of California Corporation With Multiple Cannabis Licenses

Retrieved on: 
Thursday, April 20, 2023

With the consummation of this acquisition, the Company filed a supplemental report with OTC Markets to remove the shell status symbol from the OTC Markets webpage.

Key Points: 
  • With the consummation of this acquisition, the Company filed a supplemental report with OTC Markets to remove the shell status symbol from the OTC Markets webpage.
  • The removal of this designation will take the Company one step closer to its previously announced plans for Corporate Restructuring.
  • This will allow them to supply cannabis cultivators with Landrace tissue cultures that are sometimes very hard to obtain.
  • Frank Van Vranken of Mendocino Greens Inc. said, “The opportunity to be part of GRN Holding Corporation opens pathways for growth we did not have before.

Passage Bio Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Recent Business Highlights

Retrieved on: 
Monday, March 6, 2023

ET

Key Points: 
  • ET
    PHILADELPHIA, March 06, 2023 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today reported financial results for the fourth quarter and full-year ended December 31, 2022 and provided recent business highlights.
  • 2023 is an exciting year for Passage as we focus on operational execution and generation of clinical data across our two lead programs.
  • A live audio webcast of the event will be available on the Investors & News section of Passage Bio’s website at investors.passagebio.com .
  • The archived webcast will be available on Passage Bio's website approximately two hours after the completion of the event and for 30 days following the call.

In the Lead-Up to Rare Disease Day, CENTOGENE Expands Observational Study to Advance the Genetic Understanding of Frontotemporal Dementia (FTD)

Retrieved on: 
Tuesday, February 21, 2023

and ROSTOCK, Germany and BERLIN, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced that it has extended and expanded the observational EFRONT Study to advance the genetic understanding of frontotemporal dementia (FTD).

Key Points: 
  • and ROSTOCK, Germany and BERLIN, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced that it has extended and expanded the observational EFRONT Study to advance the genetic understanding of frontotemporal dementia (FTD).
  • The announcement comes in the lead-up to Rare Disease Day (RDD) on February 28.
  • “Frontotemporal dementia is a rapidly progressing neurodegenerative disease, with no FDA-approved treatments,” said Kim Stratton, Chief Executive Officer at CENTOGENE.
  • “The EFRONT study helps us understand the genetic factors of the disease with the ultimate goal of advancing therapeutic options for patients living with FTD.”

Allina Health Joins Guardian Research Network to Drive Translational Research

Retrieved on: 
Thursday, February 2, 2023

SPARTANBURG, S.C., Feb. 2, 2023 /PRNewswire/ -- Guardian Research Network® (GRN) announced today that Allina Health, a Minnesota-based health system with 12 hospital campuses and more than 90 clinics throughout Minnesota and western Wisconsin, has joined the GRN nationwide healthcare research network. 

Key Points: 
  • SPARTANBURG, S.C., Feb. 2, 2023 /PRNewswire/ -- Guardian Research Network ® (GRN) announced today that Allina Health , a Minnesota-based health system with 12 hospital campuses and more than 90 clinics throughout Minnesota and western Wisconsin, has joined the GRN nationwide healthcare research network.
  • The relationship is part of Allina Health's commitment to expand its research program to grow translational research, linking research with clinical activities.
  • "We're excited to bring Allina Health into the GRN network," said Shirley Trainor-Thomas, vice president, Partner Network of GRN.
  • New projects, including those with Allina Health patients, are expected to drive healthcare benefits to patients across the country.

Schnitzer Steel Named Most Sustainable Company in the World by Corporate Knights

Retrieved on: 
Wednesday, January 18, 2023

Schnitzer Steel Industries, Inc. (NASDAQ: SCHN), a global leader in metals recycling, has been named the most sustainable company in the world by Corporate Knights, a leading media and research organization focused on corporate sustainability performance.

Key Points: 
  • Schnitzer Steel Industries, Inc. (NASDAQ: SCHN), a global leader in metals recycling, has been named the most sustainable company in the world by Corporate Knights, a leading media and research organization focused on corporate sustainability performance.
  • This year’s index included continued growth in the overall portion of corporate revenues and investments aligned with the sustainable economy,” said Toby Heaps, CEO, Corporate Knights.
  • In addition to Corporate Knights’ Global 100 ranking, Schnitzer has been recognized by several organizations for leading performance in sustainability, including on the topics of ethics, transparency, responsible operations, and employee engagement.
  • The Company also received the Sustainable Markets Initiative’s Terra Carta Seal, was recognized by the CDP for performance on climate and water and was rated by EcoVadis for performance in sustainable procurement.

Metal Products Manufacturers Launch Net Zero Carbon Products To Reduce Carbon Emission During The Manufacturing Process - By The Business Research Company

Retrieved on: 
Monday, December 5, 2022

LONDON, Dec. 5, 2022 /PRNewswire/ --Companies in the metal products market are focusing on the launch of net zero carbon products to limit the scope of carbon emissions generated during manufacturing process through a carbon offset and renewable energy credit purchase program.

Key Points: 
  • LONDON, Dec. 5, 2022 /PRNewswire/ --Companies in the metal products market are focusing on the launch of net zero carbon products to limit the scope of carbon emissions generated during manufacturing process through a carbon offset and renewable energy credit purchase program.
  • For example, in March 2022, Schnitzer Steel Industries, Inc., US-based manufacturers and exporters of recycled metal products, announced the launch of GRN SteelTM, a line of net zero carbon products from its Cascade Steel manufacturing operations located in McMinnville, Oregon.
  • The launch of GRN SteelTM also represents an important step towards achieving Schnitzer's sustainability goal of Net Zero Emissions by 2050.
  • As per the metal products market outlook , metal consumption by the aerospace sector will contribute towards driving the metal products market during the forecast period.

Metal Products Manufacturers Launch Net Zero Carbon Products To Reduce Carbon Emission During The Manufacturing Process - By The Business Research Company

Retrieved on: 
Monday, December 5, 2022

LONDON, Dec. 5, 2022 /PRNewswire/ --Companies in the metal products market are focusing on the launch of net zero carbon products to limit the scope of carbon emissions generated during manufacturing process through a carbon offset and renewable energy credit purchase program.

Key Points: 
  • LONDON, Dec. 5, 2022 /PRNewswire/ --Companies in the metal products market are focusing on the launch of net zero carbon products to limit the scope of carbon emissions generated during manufacturing process through a carbon offset and renewable energy credit purchase program.
  • For example, in March 2022, Schnitzer Steel Industries, Inc., US-based manufacturers and exporters of recycled metal products, announced the launch of GRN SteelTM, a line of net zero carbon products from its Cascade Steel manufacturing operations located in McMinnville, Oregon.
  • The launch of GRN SteelTM also represents an important step towards achieving Schnitzer's sustainability goal of Net Zero Emissions by 2050.
  • As per the metal products market outlook , metal consumption by the aerospace sector will contribute towards driving the metal products market during the forecast period.

Denali Therapeutics Announces Phase 1/2 Study Single Dose Healthy Volunteer Data with TAK-594/DNL593 (PTV:PGRN) and Progression to Enrolling Participants with FTD-GRN

Retrieved on: 
Tuesday, November 1, 2022

These data support dosing in participants with frontotemporal dementia and a mutation in the granulin gene (FTD-GRN) in Part B of the study.

Key Points: 
  • These data support dosing in participants with frontotemporal dementia and a mutation in the granulin gene (FTD-GRN) in Part B of the study.
  • A copy of the presentation is available on Denalis website on the Investor & Media Relations section under the Events page .
  • As previously announced, this Phase 1/2 study is a multicenter, randomized, placebo-controlled study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of DNL593.
  • Denali Therapeutics is a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier for neurodegenerative diseases.

Fourth Quarter and Fiscal 2022 Preliminary Results and Announcement of Earnings Date

Retrieved on: 
Tuesday, October 4, 2022

Schnitzer Steel Industries, Inc. (NASDAQ: SCHN) today announced preliminary results for its fourth quarter and fiscal year ended August 31, 2022.

Key Points: 
  • Schnitzer Steel Industries, Inc. (NASDAQ: SCHN) today announced preliminary results for its fourth quarter and fiscal year ended August 31, 2022.
  • The Company expects fiscal 2022 results to be the second best year in its history.
  • Fourth quarter diluted earnings per share from continuing operations to be in the range of $0.31 - $0.36.
  • The Company will report financial results for its fourth quarter and fiscal year 2022 ended August 31, 2022 on Monday, October 24, 2022.